866-997-4948(US-Canada Toll Free)

China Transdermal Drug Delivery System Market Research Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 119 Pages

Notes:
Sales, means the sales volume of Transdermal Drug Delivery System
Revenue, means the sales value of Transdermal Drug Delivery System

This report studies Transdermal Drug Delivery System in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Novartis AG
Johnson & Johnson
Mylan Pharmaceuticals, Inc
Boehringer Ingelheim GmbH
Biogel Technology, Inc.
Transdermal Technologies, Inc.
Skyepharma PLC
Watson Pharmaceuticals, Inc
3M Company
Noven Pharmaceuticals, Inc
4P Therapeutics, LLC
Echo Therapeutics, Inc
Transdermal Corp

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Electroporation
Radiofrequency
Iontophoresis
Microporation
Other
Split by Application, this report focuses on consumption, market share and growth rate of Transdermal Drug Delivery System in each application, can be divided into
Central Nervous System (CNS)
Pain Management
Cardiovascular
Other

Table of Contents

China Transdermal Drug Delivery System Market Research Report 2017
1 Transdermal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Transdermal Drug Delivery System
1.2 Transdermal Drug Delivery System Segment by Type
1.2.1 China Production Market Share of Transdermal Drug Delivery System Type in 2015
1.2.2 Electroporation
1.2.3 Radiofrequency
1.2.4 Iontophoresis
1.2.5 Microporation
1.2.6 Other
1.3 Applications of Transdermal Drug Delivery System
1.3.1 Transdermal Drug Delivery System Consumption Market Share by Application in 2015
1.3.2 Central Nervous System (CNS)
1.3.3 Pain Management
1.3.4 Cardiovascular
1.3.5 Other
1.4 China Market Size (Value) of Transdermal Drug Delivery System (2011-2021)
1.5 China Transdermal Drug Delivery System Status and Outlook
1.6 Government Policies

2 China Transdermal Drug Delivery System Market Competition by Manufacturers
2.1 China Transdermal Drug Delivery System Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Transdermal Drug Delivery System Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Transdermal Drug Delivery System Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Transdermal Drug Delivery System Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Drug Delivery System Market Competitive Situation and Trends
2.5.1 Transdermal Drug Delivery System Market Concentration Rate
2.5.2 Transdermal Drug Delivery System Market Share of Top 3 and Top 5 Manufacturers

3 China Transdermal Drug Delivery System Manufacturers Profiles/Analysis
3.1 Novartis AG
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.1.2.1 Electroporation
3.1.2.2 Radiofrequency
3.1.3 Novartis AG Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Johnson & Johnson
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.2.2.1 Electroporation
3.2.2.2 Radiofrequency
3.2.3 Johnson & Johnson 119 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Mylan Pharmaceuticals, Inc
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.3.2.1 Electroporation
3.3.2.2 Radiofrequency
3.3.3 Mylan Pharmaceuticals, Inc 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Boehringer Ingelheim GmbH
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.4.2.1 Electroporation
3.4.2.2 Radiofrequency
3.4.3 Boehringer Ingelheim GmbH Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Biogel Technology, Inc.
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.5.2.1 Electroporation
3.5.2.2 Radiofrequency
3.5.3 Biogel Technology, Inc. Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Transdermal Technologies, Inc.
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.6.2.1 Electroporation
3.6.2.2 Radiofrequency
3.6.3 Transdermal Technologies, Inc. Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Skyepharma PLC
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.7.2.1 Electroporation
3.7.2.2 Radiofrequency
3.7.3 Skyepharma PLC Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Watson Pharmaceuticals, Inc
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.8.2.1 Electroporation
3.8.2.2 Radiofrequency
3.8.3 Watson Pharmaceuticals, Inc Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 3M Company
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.9.2.1 Electroporation
3.9.2.2 Radiofrequency
3.9.3 3M Company Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Noven Pharmaceuticals, Inc
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Transdermal Drug Delivery System Product Type, Application and Specification
3.10.2.1 Electroporation
3.10.2.2 Radiofrequency
3.10.3 Noven Pharmaceuticals, Inc Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 4P Therapeutics, LLC
3.12 Echo Therapeutics, Inc
3.13 Transdermal Corp

4 China Transdermal Drug Delivery System Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Transdermal Drug Delivery System Capacity, Production and Growth (2011-2016)
4.2 China Transdermal Drug Delivery System Revenue and Growth (2011-2016)
4.3 China Transdermal Drug Delivery System Production, Consumption, Export and Import (2011-2016)

5 China Transdermal Drug Delivery System Production, Revenue (Value), Price Trend by Type
5.1 China Transdermal Drug Delivery System Production and Market Share by Type (2011-2016)
5.2 China Transdermal Drug Delivery System Revenue and Market Share by Type (2011-2016)
5.3 China Transdermal Drug Delivery System Price by Type (2011-2016)
5.4 China Transdermal Drug Delivery System Production Growth by Type (2011-2016)

6 China Transdermal Drug Delivery System Market Analysis by Application
6.1 China Transdermal Drug Delivery System Consumption and Market Share by Application (2011-2016)
6.2 China Transdermal Drug Delivery System Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaTransdermal Drug Delivery System Market Analysis by Regions (Provinces)
7.1 China Transdermal Drug Delivery System Production, Production Value and Price by Regions (Provinces)(2011-2016)
7.1.1 China Transdermal Drug Delivery System Production and Market Share by Regions (Provinces)(2011-2016)
7.1.2 China Transdermal Drug Delivery System Production Value and Market Share by Regions (Provinces)(2011-2016)
7.1.3 China Transdermal Drug Delivery System Sales Price by Regions (Provinces)(2011-2016)
7.2 China Transdermal Drug Delivery System Consumption by Regions (Provinces)(2011-2016)
7.3 China Transdermal Drug Delivery System Production, Consumption, Export and Import (2011-2016)

8 Transdermal Drug Delivery System Manufacturing Cost Analysis
8.1 Transdermal Drug Delivery System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Transdermal Drug Delivery System

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Transdermal Drug Delivery System Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Transdermal Drug Delivery System Market Forecast (2016-2021)
12.1 China Transdermal Drug Delivery System Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Transdermal Drug Delivery System Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Transdermal Drug Delivery System Production Forecast by Type (2016-2021)
12.4 China Transdermal Drug Delivery System Consumption Forecast by Application (2016-2021)
12.5 China Transdermal Drug Delivery System Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.5.1 China Transdermal Drug Delivery System Production Forecast by Regions (Provinces)(2016-2021)
12.5.2 China Transdermal Drug Delivery System Consumption Forecast by Regions (Provinces)(2016-2021)
12.5.3 China Transdermal Drug Delivery System Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Transdermal Drug Delivery System Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *